Becton Dickinson
Price data unavailable
Track BDX in your trading journalAbout Becton Dickinson
Becton Dickinson (Nasdaq/NYSE: BDX) is a Health Care Equipment company operating within the Health Care sector of the US equity market.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
The company reports trailing twelve-month revenue of $4.71B and net loss of $311.00M.
Key metrics include a return on equity of -1.3%.
Use FINOTAUR to track BDX's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $4.71B |
| Net Income (TTM) | $-311.00M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -1.29% |
| Debt-to-Equity | — |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·May 26
Microneedle Drug Delivery Systems Market to Hit USD 14.37 Billion by 2035 Driven by Self-Administered Therapies – SNS Insider
- The Motley Fool·May 25
Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market
- GlobeNewswire Inc.·May 19
Nebulizers - Global Strategic Business Report 2026 | Growing Adoption of Home Healthcare Solutions Drives Demand for Portable and User-Friendly Nebulizer Devices
Want real-time analysis on BDX?
Track it free in your trading journal. Log trades, tag setups, and review your edge.